TOPICAL USE OF HYDROXYEICOSATETRAENOIC ACID COMPOUNDS TO TREAT PSORIASIS

Details for Australian Patent Application No. 2003221707 (hide)

Owner ALCON, INC.

Inventors GAMACHE, Daniel, A.

Pub. Number AU-A-2003221707

PCT Number PCT/US03/10869

PCT Pub. Number WO2003/105824

Priority 60/389,127 14.06.02 US

Filing date 9 April 2003

Wipo publication date 31 December 2003

International Classifications

A61K 031/202

A61K 031/16 - Amides, e.g. hydroxamic acids

A61K 031/22

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/404

A61K 031/381 - having five-membered rings

A61P 017/06 Drugs for dermatological disorders

A61K 031/131 - acyclic

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/389,127 14.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-A-2003221707

3 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003221708-HYBRID STENT

2003221706-1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators